Key facts
- Nova Biochem’s last known valuation is $11.2M (Oct 2025).
- It has raised $3.7M; the latest was Seed Round ($3.1M) in Oct 2025.
- Notable investors include Forest Valley Institute, Archipelago Ventures (London), Circular Bio-based Europe Joint Undertaking, Circular Plastics Accelerator, Circulate Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Nova Biochem
- ·The full record, as it builds
Funding rounds
No funding rounds for Nova Biochem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nova Biochem
Developer of an engineering technology platform designed to create alternatives to traditional petrochemicals. The company's platform uses a water-based clean process to convert waste streams from pulping and agriculture, specifically lignin, into bio-based chemicals and building blocks, enabling businesses to utilize more sustainable materials, potentially reducing reliance on fossil fuels and creating a cleaner future.
- Sector
- Materials and Resources
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 4
- Ownership
- Privately Held (backing)
Nova Biochem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nova Biochem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nova Biochem in its N-PORT filings yet. We sweep new filings monthly.